This line seems tactically placed away from the headlines on the second page...
The Company notes, however, that it has not undertaken any independent studies on the efficacy of its new lozenge product in the treatment of SARS-CoV-2, and therefore makes no therapeutic claims in this regard.
- Forums
- ASX - By Stock
- CPH
- Ann: Creso Pharma to Develop New Hemp-Based Lozenge Product
Ann: Creso Pharma to Develop New Hemp-Based Lozenge Product, page-5
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online